Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
53,788,752
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
8,473,099
-
Shares change
-
-852,887
-
Total reported value, excl. options
-
$4,101,148
-
Value change
-
-$540,895
-
Number of buys
-
7
-
Number of sells
-
8
-
Price
-
$0.4838
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) as of Q2 2025
As of 30 Jun 2025 ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,473,099 shares of stock of the company.
Largest 10 holders included GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Allostery Investments LP, CITADEL ADVISORS LLC, Graypoint LLC, Kingsview Wealth Management, LLC, BANK OF MONTREAL /CAN/, and Fiduciary Trust Co.
This table shows 19 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.